BCA
VCYT icon

Berman Capital Advisors’s Veracyte VCYT Stock Holding History

Berman Capital Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10
Closed – – 2057
2021
Q1 		$0 Hold
10
– – ﹤0.01% 1924
2020
Q4 		$0 Hold
10
– – ﹤0.01% 1837
2020
Q3 		$0 Hold
10
– – ﹤0.01% 1781
2020
Q2 		$0 Buy
+10
New +$249 ﹤0.01% 1835

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berman Capital Advisors's VCYT Position: Q2 2021 in Review

Berman Capital Advisors sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 10 shares.

Berman Capital Advisors first reported a position in VCYT in Q2 2020 and held it in 4 quarters. The position peaked at $0 in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Berman Capital Advisors reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Berman Capital Advisors sold 10 Veracyte shares in Q2 2021.
  • Berman Capital Advisors first reported a position in Veracyte in Q2 2020 and held it in 4 quarters.
  • Berman Capital Advisors's Veracyte position peaked at $0 in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Berman Capital Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.